These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20878265)

  • 21. Propofol versus sodium thiopentone for the treatment of status epilepticus and refractory status epilepticus in dogs.
    Espiñeira I; Alzate D; Araos J; Pellegrino F; Tunesi M; Jensen M; Donati PA
    N Z Vet J; 2023 May; 71(3):128-132. PubMed ID: 36688794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus.
    Nagase H; Nishiyama M; Nakagawa T; Fujita K; Saji Y; Maruyama A
    Pediatr Neurol; 2014 Jul; 51(1):78-84. PubMed ID: 24830769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus.
    Masapu D; Gopala Krishna KN; Sanjib S; Chakrabarti D; Mundlamuri RC; Manohar N; Mariamma P; Satishchandra P; Umamaheswara Rao GS
    Indian J Crit Care Med; 2018 Jun; 22(6):441-448. PubMed ID: 29962746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propofol in the treatment of refractory status epilepticus.
    Parviainen I; Uusaro A; Kälviäinen R; Mervaala E; Ruokonen E
    Intensive Care Med; 2006 Jul; 32(7):1075-9. PubMed ID: 16791671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit.
    Francis BA; Fillenworth J; Gorelick P; Karanec K; Tanner A
    Neurocrit Care; 2019 Jun; 30(3):652-657. PubMed ID: 30484010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propylene glycol toxicity complicating use of barbiturate coma.
    Bledsoe KA; Kramer AH
    Neurocrit Care; 2008; 9(1):122-4. PubMed ID: 18270846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.
    Bellante F; Legros B; Depondt C; Créteur J; Taccone FS; Gaspard N
    J Neurol; 2016 Apr; 263(4):799-806. PubMed ID: 26914931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propofol versus thiopental sodium for the treatment of refractory status epilepticus.
    Prabhakar H; Bindra A; Singh GP; Kalaivani M
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009202. PubMed ID: 22895985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children.
    Hanna JP; Ramundo ML
    Neurology; 1998 Jan; 50(1):301-3. PubMed ID: 9443502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous noninvasive monitoring of barbiturate coma in critically ill children using the Bispectral index monitor.
    Prins SA; de Hoog M; Blok JH; Tibboel D; Visser GH
    Crit Care; 2007; 11(5):R108. PubMed ID: 17897479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of severe refractory status epilepticus in children.
    Sahin M; Menache CC; Holmes GL; Riviello JJ
    Epilepsia; 2001 Nov; 42(11):1461-7. PubMed ID: 11879350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What's new in refractory status epilepticus?
    Legriel S; Oddo M; Brophy GM
    Intensive Care Med; 2017 Apr; 43(4):543-546. PubMed ID: 27544138
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary results of the global audit of treatment of refractory status epilepticus.
    Ferlisi M; Hocker S; Grade M; Trinka E; Shorvon S;
    Epilepsy Behav; 2015 Aug; 49():318-24. PubMed ID: 25952268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can BIS monitoring be used to assess the depth of propofol anesthesia in the treatment of refractory status epilepticus?
    Musialowicz T; Mervaala E; Kälviäinen R; Uusaro A; Ruokonen E; Parviainen I
    Epilepsia; 2010 Aug; 51(8):1580-6. PubMed ID: 20132290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit.
    Candiotti KA; Gan TJ; Young C; Bekker A; Sum-Ping ST; Kahn R; Lebowitz P; Littman JJ
    Anesth Analg; 2011 Sep; 113(3):550-6. PubMed ID: 21596879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of severe hemodynamic disturbances between dexmedetomidine and propofol for sedation in neurocritical care patients.
    Erdman MJ; Doepker BA; Gerlach AT; Phillips GS; Elijovich L; Jones GM
    Crit Care Med; 2014 Jul; 42(7):1696-702. PubMed ID: 24717468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.